Sarah A Ghobish

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 5

Top Topics

Molecular Dynamics Simulations

Antimicrobial Resistance

Cell Cycle Arrest

Staphylococcus Aureus

Top Venues

Antibiotics (Basel, Switzerland)

RSC medicinal chemistry

This page only lists publications with an associated author ORCID identifier.

Publications

Rana A Elmesseri, Sarra E Saleh, Sarah A Ghobish, Taghreed A Majrashi, Heba M Elsherif, Khaled M A Aboshanab
Diclofenac and Meloxicam Exhibited Anti-Virulence Activities Targeting Staphyloxanthin Production in Methicillin-Resistant Staphylococcus aureus . Antibiotics (Basel, Switzerland) 12 (2) (2023)
Sarah A Ghobish, Khaled O Mohamed, Nahla Farag, Doaa B Farag
Novel indolyl 1,2,4-triazole derivatives as potential anti-proliferative agents: in silico studies, synthesis, and biological evaluation. RSC medicinal chemistry 15 (1) (2023)
Rana A Elmesseri, Sarra E Saleh, Sarah A Ghobish, Taghreed A Majrashi, Heba M Elsherif, Khaled M A Aboshanab
Diclofenac and Meloxicam Exhibited Anti-Virulence Activities Targeting Staphyloxanthin Production in Methicillin-Resistant Staphylococcus aureus . Antibiotics (Basel, Switzerland) 12 (2) (2023)
Sarah A Ghobish, Khaled O Mohamed, Nahla Farag, Doaa B Farag
Novel indolyl 1,2,4-triazole derivatives as potential anti-proliferative agents: in silico studies, synthesis, and biological evaluation. RSC medicinal chemistry 15 (1) (2023)
Rana A Elmesseri, Sarra E Saleh, Sarah A Ghobish, Taghreed A Majrashi, Heba M Elsherif, Khaled M A Aboshanab
Diclofenac and Meloxicam Exhibited Anti-Virulence Activities Targeting Staphyloxanthin Production in Methicillin-Resistant Staphylococcus aureus . Antibiotics (Basel, Switzerland) 12 (2) (2023)